Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.

The aim of this study was to investigat the lipid peroxidation of plasma as a marker of oxidant-induced protein damage the effects of oxygen radicals on glycated-hemoglobin and to find out the relationship between the increase level of Malondialdehyde (MDA) on HbA1C, lipid profiles and FBS (Fasting...

Full description

Bibliographic Details
Main Authors: Hanachi, Parichehr, Moghadam, Rashid Haydari, Abd Latiff, Latiffah
Format: Article
Language:English
English
Published: EuroJournals 2009
Online Access:http://psasir.upm.edu.my/id/eprint/15294/1/Investigation%20of%20lipid%20profiles%20and%20lipid%20peroxidation%20in%20patients%20with%20type%202%20diabetes.pdf
_version_ 1825945592913723392
author Hanachi, Parichehr
Moghadam, Rashid Haydari
Abd Latiff, Latiffah
author_facet Hanachi, Parichehr
Moghadam, Rashid Haydari
Abd Latiff, Latiffah
author_sort Hanachi, Parichehr
collection UPM
description The aim of this study was to investigat the lipid peroxidation of plasma as a marker of oxidant-induced protein damage the effects of oxygen radicals on glycated-hemoglobin and to find out the relationship between the increase level of Malondialdehyde (MDA) on HbA1C, lipid profiles and FBS (Fasting Blood Sugar) in patients with type 2 diabetes. This randomized study included 200 individuals, 100 cases had history of diabetic for at least 3 years (file in Isfehan hospital, Diabetic Center of Medical Sciences University) and 100 cases as the control group without history of diabetes. In both groups, level of MDA, FBS, lipid profiles and HbA1C were determined in fasting blood samples. Results showed that MDA level in diabetic patients was significantly (p<0.005) higher (0.9222 ± 0.3 μmol/L) than those in the control group (0.7428 ± 0.04μmol/L). The same was also true (p<0.05) for the level of HbA1C (9.387 ± 2.4 mg/dl in diabetic patients and 7.356 ± 1.0 mg/dl in the control group) and the FBS (163.31 ± 56mg/dl in patient group and 85.740 ± 10.1 in the control group). Furthermore, the concentration of, LDL significantly was higher (p<0.05) and the HDL level were significantly lower (p<0.05) in case group as compared to control group. The increased plasma lipid peroxidation and decreased plasma HDL that we observed in patients with type 2 diabetes mellitus indicated that these may predispose to the development of cardiovascular complications.
first_indexed 2024-03-06T07:33:55Z
format Article
id upm.eprints-15294
institution Universiti Putra Malaysia
language English
English
last_indexed 2024-03-06T07:33:55Z
publishDate 2009
publisher EuroJournals
record_format dspace
spelling upm.eprints-152942015-09-15T04:28:52Z http://psasir.upm.edu.my/id/eprint/15294/ Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes. Hanachi, Parichehr Moghadam, Rashid Haydari Abd Latiff, Latiffah The aim of this study was to investigat the lipid peroxidation of plasma as a marker of oxidant-induced protein damage the effects of oxygen radicals on glycated-hemoglobin and to find out the relationship between the increase level of Malondialdehyde (MDA) on HbA1C, lipid profiles and FBS (Fasting Blood Sugar) in patients with type 2 diabetes. This randomized study included 200 individuals, 100 cases had history of diabetic for at least 3 years (file in Isfehan hospital, Diabetic Center of Medical Sciences University) and 100 cases as the control group without history of diabetes. In both groups, level of MDA, FBS, lipid profiles and HbA1C were determined in fasting blood samples. Results showed that MDA level in diabetic patients was significantly (p<0.005) higher (0.9222 ± 0.3 μmol/L) than those in the control group (0.7428 ± 0.04μmol/L). The same was also true (p<0.05) for the level of HbA1C (9.387 ± 2.4 mg/dl in diabetic patients and 7.356 ± 1.0 mg/dl in the control group) and the FBS (163.31 ± 56mg/dl in patient group and 85.740 ± 10.1 in the control group). Furthermore, the concentration of, LDL significantly was higher (p<0.05) and the HDL level were significantly lower (p<0.05) in case group as compared to control group. The increased plasma lipid peroxidation and decreased plasma HDL that we observed in patients with type 2 diabetes mellitus indicated that these may predispose to the development of cardiovascular complications. EuroJournals 2009-03 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/15294/1/Investigation%20of%20lipid%20profiles%20and%20lipid%20peroxidation%20in%20patients%20with%20type%202%20diabetes.pdf Hanachi, Parichehr and Moghadam, Rashid Haydari and Abd Latiff, Latiffah (2009) Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes. European Journal of Scientific Research, 28 (1). pp. 6-13. ISSN 1450-216X, ESSN: 1450-202X http://www.europeanjournalofscientificresearch.com/ English
spellingShingle Hanachi, Parichehr
Moghadam, Rashid Haydari
Abd Latiff, Latiffah
Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title_full Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title_fullStr Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title_full_unstemmed Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title_short Investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes.
title_sort investigation of lipid profiles and lipid peroxidation in patients with type 2 diabetes
url http://psasir.upm.edu.my/id/eprint/15294/1/Investigation%20of%20lipid%20profiles%20and%20lipid%20peroxidation%20in%20patients%20with%20type%202%20diabetes.pdf
work_keys_str_mv AT hanachiparichehr investigationoflipidprofilesandlipidperoxidationinpatientswithtype2diabetes
AT moghadamrashidhaydari investigationoflipidprofilesandlipidperoxidationinpatientswithtype2diabetes
AT abdlatifflatiffah investigationoflipidprofilesandlipidperoxidationinpatientswithtype2diabetes